CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $950,019
- in 1 filing
Net −$950,019. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-13 | Jafar Michael M. Chief Marketing Officer | Grant or award | +40,000 | 129,000 | ||
| 2020-05-13 | Avelar Rui See Remarks | Grant or award | +40,000 | 136,802 | ||
| 2020-05-13 | SILVERNAIL LAUREN P See Remarks | Grant or award | +40,000 | 93,388 | ||
| 2020-05-13 | MOATAZEDI DAVID See Remarks | Grant or award | +100,000 | 182,070 | ||
| 2020-01-23 | Jafar Michael M. Chief Marketing Officer | Grant or award | +26,000 | 89,000 | ||
| 2020-01-23 | Jafar Michael M. Chief Marketing Officer | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2020-01-23 | Avelar Rui See Remarks | Grant or award | +26,000 | 96,802 | ||
| 2020-01-23 | Avelar Rui See Remarks | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2020-01-23 | SILVERNAIL LAUREN P See Remarks | Grant or award | +26,000 | 53,388 | ||
| 2020-01-23 | SILVERNAIL LAUREN P See Remarks | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2020-01-23 | MOATAZEDI DAVID See Remarks | Grant or award | +82,070 | 82,070 | ||
| 2020-01-23 | MOATAZEDI DAVID See Remarks | Grant or award · Stock Option (Right to Buy) | +141,910 | 141,910 | ||
| 2020-01-23 | BLANK SIMONE Director | Grant or award · Stock Option (Right to Buy) | +23,458 | 23,458 | ||
| 2020-01-23 | Hau Bosun Director | Grant or award · Stock Option (Right to Buy) | +23,458 | 23,458 | ||
| 2020-01-23 | Romine Kristine Director | Grant or award · Stock Option (Right to Buy) | +23,458 | 23,458 | ||
| 2020-01-23 | GILL DAVID N Director | Grant or award · Stock Option (Right to Buy) | +23,458 | 23,458 | ||
| 2020-01-23 | HAYMAN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +23,458 | 23,458 | ||
| 2020-01-23 | Malik Vikram Director | Grant or award · Stock Option (Right to Buy) | +23,458 | 23,458 | ||
| 2020-01-23 | FARRELL PETER C Director | Grant or award · Stock Option (Right to Buy) | +23,458 | 23,458 | ||
| 2020-01-23 | Parschauer Karah Herdman Director | Grant or award · Stock Option (Right to Buy) | +23,458 | 23,458 |
Page 14 of 16 · 303 trades